--- title: "Edwards Lifesciences: Risk Monitoring" description: "Edwards Lifesciences financial risk indicators from its SEC filings (leverage, liquidity, interest coverage, debt load) compared with peers." canonical: https://www.getswoopr.com/stocks/companies/edwards-lifesciences/risks/ source: "Swoopr Investment: https://www.getswoopr.com" --- # Edwards Lifesciences: Risk & Monitoring Guide ## Direct Answer Edwards Lifesciences's fiscal 2025 filings show no reading on these measures that stands out from common thresholds. These figures measure financial risk only; the business risks Edwards Lifesciences itself considers material are listed under Item 1A, Risk Factors, of its Form 10-K, most recently filed February 25, 2026. ## What Do Edwards Lifesciences's Financial Risk Indicators Show? | Indicator (fiscal 2025) | Edwards Lifesciences | Peer median (same SIC code) | What it measures | | --- | --- | --- | --- | | Liabilities to assets | 25% | 45% | How much of the balance sheet is funded by obligations rather than equity. | | Current ratio | 3.7x | 2.1x | Short-term assets per dollar of obligations due within a year. | | Interest coverage | n/a | -10.6x | Operating income per dollar of interest expense. | | Long-term debt to operating cash flow | 0.4x | 4.1x | Years of operating cash flow it would take to repay long-term debt. | | Net debt | -$2.3 billion | n/a | Long-term debt minus cash; negative means more cash than long-term debt. | The peer median uses 15 other companies in Swoopr's S&P 500 Equal Weight set that share the same SEC SIC code. A reading worse than the peer median is a prompt to read the filing, not a conclusion. ![Bar chart of Edwards Lifesciences balance sheet at the end of fiscal 2025: total assets $13.7 billion, total liabilities $3.4 billion, shareholders' equity $10.3 billion, long-term debt $598 million, cash and equivalents $2.9 billion.](https://www.getswoopr.com/images/charts/edwards-lifesciences-risks-balance-sheet.webp) *Edwards Lifesciences balance sheet items at the end of fiscal 2025, from the figures in the table above. Long-term debt is highlighted. Select the chart to open it full size.* ## Where Are Edwards Lifesciences's Official Risk Factors? The risks Edwards Lifesciences considers material are disclosed in Item 1A of its Form 10-K, most recently [filed February 25, 2026](https://www.sec.gov/Archives/edgar/data/1099800/000109980026000009/ew-20251231.htm). Read them with three questions in mind: which risks are specific to this company rather than generic, which have changed since the prior year's filing, and which connect to the figures above (a refinancing risk matters more when interest coverage is thin). ## Where These Numbers Come From Every figure on this page is a value Edwards Lifesciences reported in its own SEC filings, read from the SEC's XBRL data (accession 0001099800-26-000009 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary. Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation. ## Frequently Asked Questions ### Is Edwards Lifesciences highly leveraged? At the end of fiscal 2025, Edwards Lifesciences's total liabilities were 25% of total assets, against a peer median of 45%. Leverage that is normal for one industry (banks, utilities) can be high for another. ### Where are Edwards Lifesciences's official risk factors? In Item 1A, Risk Factors, of its annual report on Form 10-K, most recently filed with the SEC on February 25, 2026. The company lists the risks it considers material there; the measures on this page only quantify the financial side. ### Can Edwards Lifesciences pay its interest? Edwards Lifesciences did not report interest expense under the standard tags for fiscal 2025, so interest coverage is not computed here; its income statement and debt footnote show the details. ## References - [SEC EDGAR: Edwards Lifesciences Corp Form 10-K filed February 25, 2026](https://www.sec.gov/Archives/edgar/data/1099800/000109980026000009/ew-20251231.htm) - [SEC EDGAR: Edwards Lifesciences Corp annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1099800&type=10-K) - [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces) ## Related Pages - [Edwards Lifesciences company dossier](https://www.getswoopr.com/stocks/companies/edwards-lifesciences/) - [Edwards Lifesciences financial metrics](https://www.getswoopr.com/stocks/companies/edwards-lifesciences/metrics/) - [Edwards Lifesciences financial risk indicators](https://www.getswoopr.com/stocks/companies/edwards-lifesciences/risks/) - [Edwards Lifesciences peer comparison](https://www.getswoopr.com/stocks/companies/edwards-lifesciences/competitors/) - [Edwards Lifesciences business model and revenue mix](https://www.getswoopr.com/stocks/companies/edwards-lifesciences/business-model/) - [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/) **[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)** Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).